When these AD model mice were treated with a TNFα inhibitor, etanercept, the level of neuron injury and production of TNFα, IL-6, and CCL2 decreased and spatial, long-term, and working memory improved [24]. This evidence concerns the gene TNF and Alzheimer disease.